Empatic (zonisamide + bupropion) - Orexigen
Orexigen: BIO CEO & Investor Conference (Orexigen) - Feb 13, 2013 - "Observed Case Analysis, Phase 2b; Empatic Provides a Different Tool for the Treatment of Obesity" 
P2b data Obesity
http://www.veracast.com/bio/ceoinvestor2013/main/events/2195_orexig/pdf/Orexigen.pdf
 
Feb 13, 2013
 
.
 
a13d2a1c-2c7e-40ad-874c-4c23b5f93f22.jpg